Home / Facilities / 1000522100

GlaxoSmithKline LLC FDA Inspection Record

FEI 1000522100 · Inspections, Form 483s, warning letters and import refusals

GlaxoSmithKline LLC is an FDA-inspected facility (FEI 1000522100) located in King of Prussia, PA, US. RegDataLab tracks 1 FDA inspection at this facility.

Reviewing GlaxoSmithKline LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check GlaxoSmithKline LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Aug 23, 2013: Voluntary Action Indicated (VAI)
Inspections on record
1 (1 VAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Import refusals
3

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Aug 23, 2013Voluntary Action Indicated (VAI)No citations listed

Facility details

Company
GlaxoSmithKline LLC
Location
King of Prussia, PA (US)
Source
inspections

Import refusals

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.